HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

N B Allen Selected Research

Rituximab (Mabthera)

11/2014Rituximab for the treatment of relapses in antineutrophil cytoplasmic antibody-associated vasculitis.
9/2013Clinical outcomes of remission induction therapy for severe antineutrophil cytoplasmic antibody-associated vasculitis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


N B Allen Research Topics

Disease

2Vasculitis (Vasculitides)
11/2014 - 09/2013
1Major Depressive Disorder (Major Depressive Disorders)
09/2014
1Granulomatosis with Polyangiitis (Wegener's Granulomatosis)
09/2013
1Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
09/2013
1Opioid-Related Disorders (Opiate Addiction)
11/2008

Drug/Important Bio-Agent (IBA)

2Rituximab (Mabthera)FDA Link
11/2014 - 09/2013
2Antineutrophil Cytoplasmic Antibodies (ANCA)IBA
11/2014 - 09/2013
1Serotonin Plasma Membrane Transport Proteins (Serotonin Transporter)IBA
09/2014
1Azathioprine (Imuran)FDA LinkGeneric
09/2013
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
09/2013
1Prednisone (Sone)FDA LinkGeneric
09/2013
1Pharmaceutical PreparationsIBA
11/2008

Therapy/Procedure

1Therapeutics
09/2013
1Remission Induction
09/2013